Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-71,412
Closed -$3.21M 6
2015
Q4
$3.21M Sell
71,412
-127,325
-64% -$5.62M 0.24% 93
2015
Q3
$7.99M Sell
198,737
-83,261
-30% -$3.93M 0.21% 114
2015
Q2
$13.8M Sell
281,998
-8,928
-3% -$429K 0.23% 109
2015
Q1
$13.5M Sell
290,926
-3,635
-1% -$167K 0.23% 109
2014
Q4
$13.3M Sell
294,561
-4,223
-1% -$184K 0.22% 103
2014
Q3
$12.4M Buy
298,784
+34,207
+13% +$1.45M 0.22% 109
2014
Q2
$10.8M Buy
264,577
+10,588
+4% +$416K 0.19% 130
2014
Q1
$9.78M Sell
253,989
-33,806
-12% -$1.3M 0.17% 134
2013
Q4
$11M Buy
287,795
+905
+0.3% +$33.4K 0.19% 127
2013
Q3
$9.52M Buy
286,890
+47,474
+20% +$1.67M 0.17% 131
2013
Q2
$8.35M Buy
+239,416
New +$8.78M 0.15% 137

Other funds holding ABT

Curian Capital's ABT Position: Q1 2016 in Review

Curian Capital sold out of Abbott (ABT) in Q1 2016, closing a stake of 71,412 shares — an estimated $3.21M sold.

Curian Capital first reported a position in ABT in Q2 2013 and held it in 11 quarters. The position peaked at $13.8M in Q2 2015. 1,470 funds tracked by Wall St. Rank hold ABT as of Q1 2016.

  • Curian Capital reported no remaining Abbott position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 71,412 Abbott shares in Q1 2016, an estimated $3.21M.
  • Curian Capital first reported a position in Abbott in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Abbott position peaked at $13.8M in Q2 2015.
  • 1,470 funds tracked by Wall St. Rank held Abbott as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.